{"schema_version":"secwatch.filing_event.v1","accession":"0000730464-24-000004","form_type":"8-K/A","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2024-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.858537+00:00","generated_at":"2026-06-03T23:41:51.660109+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Adtalem finalizes separation agreement with ex-President Danaher; details severance terms","bullets":["Severance of $1,014,390 (1x salary + 70% MIP target) payable in 12 monthly installments.","FY23 MIP award set to 0% by CEO; no FY23 payout and no pro-rated FY24 MIP.","Unvested LTI awards (RSUs, PSUs, options) will continue to vest per award agreements.","One-time lump sum of $14,513 for COBRA subsidy for dependents; counsel fees of $62,000 paid.","Standard noncompete, nonsolicitation, confidentiality covenants apply."],"urls":{"canonical":"https://secwatch.observer/filing/0000730464-24-000004","json":"https://secwatch.observer/filing/0000730464-24-000004.json","markdown":"https://secwatch.observer/filing/0000730464-24-000004.md","text":"https://secwatch.observer/filing/0000730464-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000073046424000004/0000730464-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000073046424000004/atge-20230906x8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T23:41:51.660109+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"76c0ef474b","claim":"Dr. John Danaher departed as President, Medical & Veterinary at Covista Inc..","evidence_excerpt":"reporting that Dr. John Danaher President, Medical & Veterinary was leaving Adtalem effective September 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/730464/000073046424000004/0000730464-24-000004-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"left"},{"label":"Role","value":"President, Medical & Veterinary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}